CVI Holdings’s Oragenics OGEN Stock Holding History

CVI Holdings’s Portfolio OGEN Stock Details OGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-391	Closed	-$345K	–	57
2019 Q2	$345K	Sell	391 -1,493	-79%	-$1.37M	0.4%	29
2019 Q1	$1.98M	Buy	+1,884	New	+$2.96M	1.88%	12

Other funds holding OGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

HCS

Harvest Capital Strategies San Francisco, California $73.7M AUM 7.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

CVI Holdings's OGEN Position: Q3 2019 in Review

CVI Holdings sold out of Oragenics (OGEN) in Q3 2019, closing a stake of 391 shares — an estimated $345K sold.

CVI Holdings first reported a position in OGEN in Q1 2019 and held it in 2 quarters. The position peaked at $1.98M in Q1 2019. 13 funds tracked by Wall St. Rank hold OGEN as of Q3 2019.

CVI Holdings reported no remaining Oragenics position as of Q3 2019 after selling out during the quarter.
CVI Holdings sold 391 Oragenics shares in Q3 2019, an estimated $345K.
CVI Holdings first reported a position in Oragenics in Q1 2019 and held it in 2 quarters.
CVI Holdings's Oragenics position peaked at $1.98M in Q1 2019.
13 funds tracked by Wall St. Rank held Oragenics as of Q3 2019.

Based on CVI Holdings's 13F filing for Q3 2019, filed 14 Nov 2019.